ロード中...
NCMP-23. FACIAL PALSY INDUCED BY CANCER IMMUNOTHERAPY: A SINGLE CENTER RETROSPECTIVE STUDY
Monoclonal antibodies to Cytotoxic T-lymphocyteassociated antigen 4 (CTLA-4) [ipilimumab] and programmed cell death (PD1) receptor or ligand (PDL1) [pembrolizumab, nivolumab, atezolizumab] are increasingly used for the treatment of metastatic cancer. The augmented immune response enabled by these ag...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216894/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.822 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|